MOH — authorised 20 October 2006
- Marketing authorisation holder: TAKEDA GMBH
- Status: likely_approved
MOH authorised Omnaris on 20 October 2006
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. MOH authorised it on 20 October 2006.
TAKEDA GMBH holds the Israeli marketing authorisation.